Serious heart attacks are more likely to happen at the start of the working week than at any other time, according to new research.
Cutaneous wounds are extremely common and can pose problems when left untreated. Researchers have now developed an easy and quick fix for this using PAINT.
Osimertinib, specially developed to treat the most common type of lung cancer called non-small cell lung cancer, showed promise in 88 percent of patients.
An innovation in MRI imaging enhances the magnetic signal of molecules, unveiling metabolic changes within cells and providing information for healthcare.
Stay a step ahead with The Blueprint
Get the latest stories about the disruptive technologies, science, engineering, and innovation delivered to your inbox, every day.
Researchers from the Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen have found that an intestinal bacteria may be the key to a long and healthy life.
Scientists have discovered that a chemical formed during the digestion of a widely used sweetener is genotoxic, causing DNA damage.
This is the first time that researchers have examined PFAS documents spanning 45 years (1961 to 2006).
The National Eating Disorder Association took its chatbot called Tessa offline two days before it was set to replace human associates.
A new study is revealing that damage to the brains of patients operated on for brain tumors may be assessed by measuring biomarkers in the blood.
NICE approves rimegepant as a preventive treatment for migraines, offering hope to those who have failed previous therapies.